Background and Aims: A considerable number of au-toimmune hepatitis (AIH) patients completely or partially fail on first-line treatment. Several studies on the use of calcineurin inhibitors (CNIs)... Show moreBackground and Aims: A considerable number of au-toimmune hepatitis (AIH) patients completely or partially fail on first-line treatment. Several studies on the use of calcineurin inhibitors (CNIs) in the treatment of AIH have been published without focusing on indication. The aim was to assess the efficacy of CNIs in the treatment of adult AIH patients, specifically focusing on indication: first-line intolerant and with first-line insufficient response (failure to achieve or maintain remission), and with second versus third-line treatment. Methods: A literature search included studies on the use of CNIs in adult AIH. Patients with past or present use of CNIs from the Dutch AIH group cohort were added. The primary endpoint was biochemical remission while using CNIs. Secondary endpoints were biochemical response, treatment failure, and adverse effects. Results: Twenty studies from the literature and nine Dutch patients were included describing the use of cyclosporine in 59 and tacrolimus in 219 adult AIH patients. The CNI remission rate was 53% in patients with insufficient response to first-line treatment and 67% in patients intolerant to first-line treat-ment. CNIs were used as second-line treatment in 73% with a remission rate of 52% and as third-line treatment in 22% with a remission rate of 26%. Cyclosporine was discontin-ued in 13% and tacrolimus in 11% of patients because of adverse events. Conclusions: CNIs as rescue treatment in adult AIH patients are reasonably effective and safe both with insufficient response or intolerance to previous treat-ment. Prospective studies are needed. Show less
After using C0-monitoring as the tool for therapeutic drug monitoring of cyclosporine for many years, studies suggested that C2-monitoring might be better. After switching 31 liver transplant... Show moreAfter using C0-monitoring as the tool for therapeutic drug monitoring of cyclosporine for many years, studies suggested that C2-monitoring might be better. After switching 31 liver transplant patients using cyclosporine from C0 via C2 to flexible limited sampling models (LSM), combinations of blood sampling time points 0+2h (r_=0.94); 0+1+2h (r_=0.94); 0+1+3h (r_=0.92); 0+2+3h (r_=0.92) and 0+1+2+3h (r_=0.96) showed excellent correlation with AUC0-12h with acceptable precision and bias. When evaluating the LSM0+1+2+3h model in the 18 months after introduction there was no significant change in average cyclosporine dose and creatinine clearance, compared to previous C2-monitoring. Especially LSM0+2h was optimal in terms of accuracy, ease-of-use and intrapatient variability. When optimizing tacrolimus monitoring after calculating limited sampling formulas (LSF) and LSM single and multiple-point combinations showed good correlations with AUC0-12h. The best single point calculation in terms of estimating systemic tacrolimus exposure using LSM were LSM 4h (r_=0.97) and LSM 6h (r_=0.97). During the study of the pharmacokinetic behaviour of MMF we found a wide range in MPA clearance in the population (8.08__57.47 L/h). Looking at possible sources of this variability in MPA clearance we divided our group, based on clinical selection, into two groups (with and without calcineurin inhibitors). These groups were used for further development of LSM for monitoring MPA. The combination 0-_-1-2h showed very good correlations with trapezoidal AUC0-12h for both models, with acceptable bias and precision. Show less
Over the last decades, restoration of renal function by renal allograft transplantation has evolved into the preferred treatment option for patients with end stage renal disease. The introduction... Show moreOver the last decades, restoration of renal function by renal allograft transplantation has evolved into the preferred treatment option for patients with end stage renal disease. The introduction of the calcineurin inhibitors (CNI) cyclosporine and tacrolimus have significantly contributed to this success. Adverse drug effects, together with the large inter-individual variation in pharmacokinetics of both drugs necessitates therapeutic drug monitoring (TDM). Nowadays, TDM is routinely performed by drug concentration measurement in blood. Unfortunately, the incidence of acute allograft rejection episodes is still 10-20% within first year after transplantation. A strategy to improve clinical immunesuppresion early after transplantation is improved monitoring. Next to advanced pharmacokinetic monitoring, such as estimated AUC monitoring, the development of pharmacodynamic markers could theoretically contribute to improve CNI therapy. Pharmacodynamic monitoring strategies, however, are still in an experimental phase and have not proven clinical benefit yet. They carry the theoretical advantage of monitoring the true effectiveness of immunosuppressive therapy. This led us to investigate pharmacodynamic monitoring as potential tool to guide drug dosing. We choose calcineurin activity as pharmacodynamic marker for monitoring and in this thesis, the analytical aspects, fundamental characteristics and insights in clinical usefulness of calcineurin activity measurement as a pharmacodynamic marker for CNI were investigated. Show less
__Bones can break, muscles can atrophy, glands can loaf, even the brain can go to sleep, without immediately endangering our survival, but when the kidneys fail to manufacture the proper kind of... Show more__Bones can break, muscles can atrophy, glands can loaf, even the brain can go to sleep, without immediately endangering our survival, but when the kidneys fail to manufacture the proper kind of blood neither bone, muscle, gland nor brain can carry on__. This quote from Homer Smith's book 'From Fish to Philosopher' indicates the importance of the kidney for the maintenance of the harmonious composition of body fluids __ a function the kidney performs in a way that joins efficacy with elegance. Some of these processes are lined out in this thesis. The first chapter gives an introduction to kidney development, anatomy, and function, as well as a description of malfunction of the kidney, focusing on the development of proteinuria and failure of kidney transplants. The subsequent chapters describe studies that have been performed to investigate the biological mechanism that underly the development of proteinuria and long-term renal transplant failure. Show less